Inestabilidad de la planta profesional en los CDC altera proyectos de VIH y desperdicia dinero, dicen investigadores

Decenas de expertos en VIH de los Centros para el Control y Prevención de Enfermedades (CDC) recibieron correos electrónicos el miércoles 11 de junio revocando las notificaciones de despido recibidas diez semanas atrás. Sin embargo, el daño a sus proyectos podría ser permanente, y las restricciones continuas a sus investigaciones perjudicarán vidas, dijeron científicos de…

Read More

AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy

Enhertu is currently approved as a second-line treatment for HER2-positive metastatic breast cancer. The new results for the AstraZeneca and Daiichi Sankyo drug in the first-line setting are important because many patients do not live long enough to receive a second-line cancer therapy. The post AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line…

Read More

Journalists Dig Into Megabill’s Slashing of Medicaid. Plus, How To Avoid Tick Bites.

KFF Health News Nevada correspondent Jazmin Orozco Rodriguez discussed the potential impact of Medicaid cuts on rural hospitals on KNPR’s “State of Nevada” on July 17. Click here to hear Orozco Rodriguez on “State of Nevada.” Read Orozco Rodriguez’s “‘One Big Beautiful Bill’ Would Batter Rural Hospital Finances, Researchers Say.” KFF Health News chief Washington…

Read More